We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$138B
AUM Growth
+$19.4B
Cap. Flow
+$7.6B
Cap. Flow %
5.51%
Top 10 Hldgs %
15.42%
Holding
4,486
New
399
Increased
2,092
Reduced
1,353
Closed
351

Sector Composition

Rank Sector Weight
1 Healthcare 12.22%
2 Technology 11.9%
3 Financials 9.98%
4 Consumer Discretionary 7.32%
5 Communication Services 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STBA icon
2576
S&T Bancorp
STBA
$1.85B
$1.89M ﹤0.01%
46,996
+7,844
+20% +$297K
VIV icon
2577
Telefônica Brasil
VIV
$20.3B
$1.89M ﹤0.01%
+132,001
New +$1.76M
ANF icon
2578
Abercrombie & Fitch
ANF
$4.84B
$1.89M ﹤0.01%
109,213
-47,463
-30% -$785K
JACK icon
2579
Jack in the Box
JACK
$324M
$1.88M ﹤0.01%
24,136
+1,011
+4% +$83.7K
ALGT icon
2580
Allegiant Air
ALGT
$2.78B
$1.88M ﹤0.01%
10,792
-11,443
-51% -$1.89M
CVSA
2581
Covista Inc
CVSA
$4.34B
$1.88M ﹤0.01%
53,738
+418
+0.8% +$14.4K
SKYW icon
2582
Skywest
SKYW
$4.42B
$1.88M ﹤0.01%
29,050
-9,542
-25% -$581K
CIVI
2583
DELISTED
Civitas Resources
CIVI
$1.88M ﹤0.01%
80,294
-46,404
-37% -$918K
BBT
2584
Beacon Financial Corp
BBT
$2.69B
$1.87M ﹤0.01%
56,906
+21,504
+61% +$674K
AIMT
2585
DELISTED
Aimmune Therapeutics
AIMT
$1.87M ﹤0.01%
55,872
+22,454
+67% +$628K
DCPH
2586
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$1.86M ﹤0.01%
29,942
+15,635
+109% +$743K
ADNT icon
2587
Adient
ADNT
$1.65B
$1.86M ﹤0.01%
87,601
-82,248
-48% -$1.82M
PRNB
2588
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$1.86M ﹤0.01%
33,956
+25,170
+286% +$940K
APPF icon
2589
AppFolio
APPF
$6.79B
$1.86M ﹤0.01%
16,907
+2,545
+18% +$260K
HMN icon
2590
Horace Mann Educators
HMN
$2.09B
$1.86M ﹤0.01%
42,569
+3,785
+10% +$167K
CLDR
2591
DELISTED
Cloudera, Inc.
CLDR
$1.86M ﹤0.01%
159,712
-413,834
-72% -$3.96M
CLVS
2592
DELISTED
Clovis Oncology, Inc.
CLVS
$1.86M ﹤0.01%
178,056
+13,922
+8% +$101K
CVGW
2593
DELISTED
Calavo Growers
CVGW
$1.85M ﹤0.01%
20,470
-53,226
-72% -$4.76M
PPC icon
2594
Pilgrim's Pride
PPC
$6.65B
$1.85M ﹤0.01%
56,729
+4,983
+10% +$155K
SU icon
2595
PUT
Suncor Energy
SU
$77.9B
$1.85M ﹤0.01%
56,500
MNRL
2596
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
$1.85M ﹤0.01%
+86,310
New +$1.68M
APLS
2597
DELISTED
Apellis Pharmaceuticals
APLS
$1.85M ﹤0.01%
60,388
+8,848
+17% +$245K
RWLS
2598
DELISTED
Direxion Russell Large Over Small Cap ETF
RWLS
$1.85M ﹤0.01%
29,000
SAH icon
2599
Sonic Automotive
SAH
$2.76B
$1.85M ﹤0.01%
59,620
+24,233
+68% +$767K
ESGR
2600
DELISTED
Enstar Group
ESGR
$1.85M ﹤0.01%
8,920
+759
+9% +$152K

Similar funds

Credit Suisse's Q4 2019 Portfolio in Review

As of Q4 2019, Credit Suisse held 4,486 positions worth $138B, up 16% from $119B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Credit Suisse deployed $7.6B of net new capital in Q4 2019, opening 399 new positions and adding to 2,092 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Vanguard Extended Market ETF, an estimated $566M trimmed.

  • Credit Suisse's largest Q4 2019 buy was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $1.28B increase.
  • Credit Suisse's biggest Q4 2019 reduction was Vanguard Extended Market ETF, cutting an estimated $566M.
  • Credit Suisse fully exited Celgene Corp in Q4 2019, selling an estimated $685M.
  • Credit Suisse's ten largest holdings make up 15% of its $138B portfolio in Q4 2019.
  • Credit Suisse opened 399 new positions and closed 351 in Q4 2019.
  • Credit Suisse's portfolio value rose 16% quarter-over-quarter to $138B.

Based on Credit Suisse's 13F filing for Q4 2019, filed 12 Feb 2020.